Ghana’s Shrimp-Shell Farm Input Pilot Must Prove Its Economics
A Ghanaian agribusiness consortium and Türkiye’s ChitoGlobal plan field trials of chitosan products made from discarded shrimp and crab shells. The pilot could test a new use for seafood waste, but crop efficacy, regulatory approval, supply and cost must be established before farmers can judge its value.
A Ghanaian agribusiness consortium and a Türkiye-based biotechnology company are preparing to test crop products derived from discarded shrimp and crab shells on Ghanaian farms. The agreement is at the research-and-trial stage: the African Agribusiness Consortium (AAC), a Jospong Group subsidiary, and ChitoGlobal Biotechnology have signed a memorandum of understanding to evaluate chitosan-based products under local farming conditions. The announcement is interesting less as a product launch than as a test of whether a waste-derived input can pass from laboratory promise to affordable, regulated farm use.
According to MyJoyOnline, the proposed trials will examine seed and plant protection, disease response, resilience in dry spells, soil quality, crop yields and the possibility of lower costs than some conventional inputs. The companies have not published trial results, a product price, a registration decision or a timeline for commercial sales. Those gaps are normal at the start of a pilot, but they are precisely what farmers and regulators will need answered before the products can be recommended broadly.
Chitosan has potential, but outcomes depend on the formulation
Chitosan is produced from chitin, a material found in the shells of crustaceans. Research has studied its use as a seed treatment, plant-defense elicitor and possible tool in disease management. A 2024 review in the Journal of Plant Growth Regulation describes promising effects in some settings, while also stressing that responses can vary with the crop, treatment, concentration and application method. The review found results for root treatments in soil to be inconclusive and called for additional field-based research.
That distinction matters. Evidence that an ingredient can affect plants in controlled experiments does not prove that a particular commercial product will raise yields or protect crops in Ghana. Chitosan products may differ in molecular properties, concentration, carrier and method of application. Soil type, rainfall, crop variety, disease pressure and timing can change performance. A result from one crop or research setting cannot simply be transferred to another.
The Ghana trials should therefore compare treated plots with suitable controls and commonly used practices, across more than one location or growing condition where feasible. Measuring plant appearance alone would be inadequate. Useful results would include crop survival, disease incidence, marketable yield, quality, application frequency and any unintended effects on growth. Publishing the methods and results, including neutral or negative findings, would help farmers and agronomists assess whether an observed benefit is reproducible.
Farm economics are as important as biological efficacy
A product may work in a field and still fail commercially if it costs too much, needs several applications or is difficult to obtain at the right time. AAC says it will assess affordability and commercial viability. That assessment should compare total cost per hectare, including product, labour, equipment and transport, against the input or practice being replaced. If the product is an addition rather than a substitute, the calculation should show whether extra yield or reduced losses cover the added expense.
This is especially relevant if the intended users include smallholder farmers. Farmers need clear guidance on dosage, storage, mixing and timing, along with advice on what to do if the product does not perform as expected. Demonstrations and extension support can make a technically sound input usable; they cannot compensate for a price that leaves the farmer with no reliable margin. The business case will ultimately rest on measured costs and returns, not on the appeal of a natural origin story.
The consortium itself grows rice, maize, vegetables and soybeans commercially and works with farmers on mechanisation, finance and market access, according to the report. That could provide a practical setting for trials and farmer engagement. But results on consortium-operated farms should be interpreted alongside tests with independent producers and differing farm sizes. A technology that works in a managed commercial operation may need different packaging, application advice or distribution to fit small farms.
Local production depends on a reliable shell supply
The partnership’s circular-economy proposition is that discarded seafood shells could become a useful agricultural material. For that to become local manufacturing, Ghana would need more than access to a processing formula. The partners would have to establish how much suitable shell waste is available, where it is generated, how it can be collected and cleaned, and whether supply is consistent through the year. The MyJoyOnline report says AAC will assess whether enough raw material is available; it does not provide a volume estimate.
Processing also requires quality control. Raw material composition, contamination risks, extraction methods and product specifications need to be consistent from batch to batch. The location and cost of processing, energy and water use, transport and safe management of residual waste all affect whether the local value chain is commercially and environmentally sound. Until those issues are examined, “made from waste” describes the feedstock concept, not a proven low-cost or low-impact product.
Ghana already has other circular approaches to agricultural inputs. UNDP’s Waste2Compost programme, implemented with local partners, turns organic municipal waste into compost through facilities in several regions. That is a different process and product, but it shows why local waste-to-input projects should be judged on practical questions: feedstock reliability, quality standards, farmer demand and the economics of collection and distribution.
Regulation should shape the trial from the start
How the product is classified will depend on its composition and the claims made for it. Ghana’s Ministry of Food and Agriculture says its Pesticides and Fertilizer Regulatory Division oversees fertilizer product registration and certification, including laboratory analysis, bio-efficacy trials and field-performance verification. The Environmental Protection Authority lists pesticide control and regulation among its responsibilities under the Environmental Protection Act, 2025. The companies have said they will work with Ghanaian standards and environmental authorities before introduction.
Early engagement with the relevant bodies can make trials more useful, not merely satisfy a final paperwork step. Regulators can clarify what evidence is needed for the product’s proposed claims, what safety and quality data must be collected, and which approval route applies. That helps prevent a common mismatch: research that measures one benefit while commercial marketing later makes broader claims that the data do not support.
What a credible next phase would show
The next milestones to watch are a published trial protocol, the crops and locations selected, the control treatments used, registration steps, and an independently reviewable account of results. A later local-production decision should disclose whether feedstock volumes, processing costs and quality standards support manufacturing at commercial scale. Farmers should be able to see product prices and compare them with verified changes in yield or input costs before deciding to adopt.
Ghana’s shrimp-shell chitosan pilot has an appealing combination of biotechnology, waste valorisation and agribusiness. But its promise is still a hypothesis. If field evidence shows reliable crop benefits, regulators approve the relevant claims, and local feedstock can support affordable production, the partnership could offer a new tool and a new market for a discarded material. If any of those conditions fails, the most useful outcome may still be a clearer understanding of what the technology can and cannot do in Ghanaian agriculture. For now, the right measure is not enthusiasm at the signing table; it is what the trials can prove on farms.
As of November 22, 2026, the partnership has announced planned research and field trials, not completed results or a registered commercial product. Statements about potential benefits are objectives to be tested, not confirmed effects in Ghana.


